Though the deficiency of a functional low density lipoprotein receptor is the fundamental defect in the disease familial hypercholesterolemia, the resultant alterations in lipid metabolism in these patients are not well understood. This research investigates plasma lipoprotein metabolism in heterozygous familial hypercholesterolemia (FH) and builds upon the general hypothesis that in FH the plasma lipid transport system is driven by the increased hepatic cholesterol ester (CE) content which occurs in this disease. Human subjects, normal controls and FH patients, will be studied on a 45% carbohydrate, 40% fat diet, and the latter will be restudied on a 90% carbohydrate diet which will induce increased VLDL-triglyceride (TG) secretion and decreased hepatic cholesterol synthesis. The experiment will utilize in vivo tracers of 3H-leucine, 14C-mevalonatic acid and 3H-glycerol to measure the secretory rates, residence times and plasma transports of apolipoprotein B(100), apoA1, apoA2, CE and TG. The measured specific radioactivity of these substances will be analyzed by compartmental modeling using the SAAM/CONSAM program. The investigation will test four specific mechanistic hypotheses to explain known abnormalities in this disease, as follows: 1. Increased hepatic CE content determines secretion of apoB particles enriched in CE rather than TG, which are secreted as IDL/LDL sized lipoproteins. 2. The residence time of VLDL-apoB in FH is prolonged both as a consequence of reduced clearance from plasma of VLDL and their remnant particles and because of increased CE content of the remnants, which impairs their conversion to IDL and LDL. 3. In FH, decreased availability of TG-enriched VLDL becomes rate limiting for CETP catalyzed CE/TG transfer, thus reducing the transfer rate of CE from HDL to apoB. 4. The removal of CE from plasma occurs not only by lipoprotein particle clearance through various receptor mediated mechanisms but also by hepatic CE/TG exchange, a possible means by which the CE content of the liver becomes increased in this disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL029394-09
Application #
3340489
Study Section
Metabolism Study Section (MET)
Project Start
1982-09-01
Project End
1995-03-31
Budget Start
1992-04-17
Budget End
1993-03-31
Support Year
9
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Fisher, W R; Venkatakrishnan, V; Fisher, E S et al. (1997) The 3H-leucine tracer: its use in kinetic studies of plasma lipoproteins. Metabolism 46:333-42
Venkatakrishnan, V; Fisher, W R; Zech, L A (1997) Determination of the radiation dose from administered apolipoprotein tracers in humans. Metabolism 46:1231-9
Fisher, W R; Venkatakrishnan, V; Zech, L A et al. (1995) Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans. J Lipid Res 36:1618-28
Fisher, W R; Zech, L A; Stacpoole, P W (1994) ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm. Arterioscler Thromb 14:501-10
Stacpoole, P W; von Bergmann, K; Kilgore, L L et al. (1991) Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet. J Lipid Res 32:1837-48
Fisher, W R; Zech, L A; Kilgore, L L et al. (1991) Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer. J Lipid Res 32:1823-36
Beltz, W F; Kesaniemi, Y A; Miller, N H et al. (1990) Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein. J Lipid Res 31:361-74
Stacpoole, P W; Alig, J; Kilgore, L L et al. (1988) Lipodystrophic diabetes mellitus. Investigations of lipoprotein metabolism and the effects of omega-3 fatty acid administration in two patients. Metabolism 37:944-51
Patterson, B W; Hansard 2nd, S L; Ammerman, C B et al. (1986) Kinetic model of whole-body vanadium metabolism: studies in sheep. Am J Physiol 251:R325-32
Patterson, B W; Lee, A M (1986) Self-association and phospholipid binding properties of iodinated apolipoprotein A-I. Biochemistry 25:4953-7

Showing the most recent 10 out of 12 publications